Re:First gene therapy for Tay-Sachs disease successfully giv...
by jostmey on Sunday February 20, 2022 @06:40PM
(#30410341)
Many exciting new biotechnologies are incredibly expensive like gene therapy, T cell therapy, or some other radical life-saving therapy. Regulations are one factor driving up costs, as well as the manufacturing costs. It is not easy and really annoying when people think it is overpriced
[ Parent
| on HN ]
Re:First gene therapy for Tay-Sachs disease successfully giv...
by DoreenMichele on Sunday February 20, 2022 @06:48PM
(#30410399)
When you compare such to current costs of conventional treatment, it's often not that bad. That's before you factor in pain, suffering and lost productivity of the patient and their caregivers.
The problem is figuring out how to pay for such things to begin with.